Published in Proc Natl Acad Sci U S A on January 26, 2004
Signaling pathways in aged T cells - a reflection of T cell differentiation, cell senescence and host environment. Semin Immunol (2012) 1.18
ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis. J Immunol (2009) 1.06
Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther (2010) 1.05
What does tumour necrosis factor excess do to the immune system long term? Ann Rheum Dis (2005) 0.98
Inhibitor of kappa B epsilon (IκBε) is a non-redundant regulator of c-Rel-dependent gene expression in murine T and B cells. PLoS One (2011) 0.89
Genomic expression profiling of TNF-alpha-treated BDC2.5 diabetogenic CD4+ T cells. Proc Natl Acad Sci U S A (2008) 0.86
The serum protein profile of early parity which induces protection against breast cancer. Oncotarget (2016) 0.75
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A (1993) 11.95
Signal transduction by lymphocyte antigen receptors. Cell (1994) 10.63
Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (1995) 7.40
Antigen receptor tail clue. Nature (1989) 7.32
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex. Cell (1988) 3.59
Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature (1988) 3.46
The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell (1992) 3.11
Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem (2002) 2.62
Building a multichain receptor: synthesis, degradation, and assembly of the T-cell antigen receptor. Proc Natl Acad Sci U S A (1987) 2.58
Molecular cloning of the zeta chain of the T cell antigen receptor. Science (1988) 2.58
On the dynamics of TCR:CD3 complex cell surface expression and downmodulation. Immunity (2000) 2.48
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med (1998) 2.42
Genetic and mutational analysis of the T-cell antigen receptor. Annu Rev Immunol (1990) 2.38
Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes. Science (1983) 2.21
Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain. J Exp Med (1993) 2.17
Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci U S A (1990) 2.13
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med (1997) 1.92
Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett (2002) 1.86
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest (1994) 1.81
Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest (1998) 1.80
A new subunit of the human T-cell antigen receptor complex. Nature (1987) 1.38
Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol (1997) 1.34
Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J Biol Chem (2001) 1.27
Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface. J Immunol (2001) 1.25
T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membrane. J Exp Med (1998) 1.22
Rapid turnover of the CD3 zeta chain independent of the TCR-CD3 complex in normal T cells. Immunity (1995) 1.19
Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J Immunol (2000) 1.19
Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways. Mol Cell Biol (2002) 1.17
The transmembrane adaptor protein TRIM regulates T cell receptor (TCR) expression and TCR-mediated signaling via an association with the TCR zeta chain. J Exp Med (2001) 1.11
T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles. Arthritis Rheum (1999) 1.11
Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun (1998) 1.10
Subunit interactions within the T-cell antigen receptor: clues from the study of partial complexes. Proc Natl Acad Sci U S A (1988) 1.08
Caspase-mediated degradation of T-cell receptor zeta-chain. Cancer Res (1999) 1.05
HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest (1996) 1.02
Crippling of CD3-zeta ITAMs does not impair T cell receptor signaling. Immunity (1999) 1.02
Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased expression of TCR zeta-chain in patients with systemic lupus erythematosus. J Immunol (2002) 0.98
T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA. Arthritis Rheum (2001) 0.93
New simplified molecular design for functional T cell receptor. Eur J Immunol (1993) 0.91
Granzyme B-mediated degradation of T-cell receptor zeta chain. Cancer Res (2002) 0.86
Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta. Gene Ther (2000) 0.83
Mutations in T cell receptor zeta chain mRNA of peripheral T cells from systemic lupus erythematosus patients. J Autoimmun (1998) 0.80
Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilonRI-signaling gamma subunit. J Immunol (1998) 0.80
Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus expressing the 10A1 envelope protein. J Gene Med (2002) 0.77
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis (2012) 1.78
Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells. Arthritis Rheum (2013) 1.71
Early and extensive erosiveness in peripheral joints predicts atlantoaxial subluxations in patients with rheumatoid arthritis. Arthritis Rheum (2003) 1.62
Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum (2008) 1.61
Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood (2007) 1.61
Targeting cytokines to inflammation sites. Nat Biotechnol (2003) 1.60
Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett (2011) 1.42
Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev (2008) 1.42
The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). Prog Retin Eye Res (2004) 1.33
Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett (2007) 1.22
A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. Am J Pathol (2003) 1.20
Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells. Blood (2004) 1.14
Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS One (2012) 1.13
The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation. Arthritis Res Ther (2005) 1.13
Polymorphisms in the CD3Z gene influence TCRzeta expression in systemic lupus erythematosus patients and healthy controls. J Immunol (2008) 1.12
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur J Immunol (2013) 1.07
Immune-mediated pathways in chronic inflammatory arthritis. Best Pract Res Clin Rheumatol (2008) 1.06
Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes. Eur J Immunol (2002) 1.05
Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke. Proc Natl Acad Sci U S A (2012) 1.02
Expression profiling of lymphocyte plasma membrane proteins. Mol Cell Proteomics (2003) 0.98
Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking. PLoS Genet (2013) 0.96
Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints. Scand J Rheumatol (2010) 0.96
Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation. Arthritis Rheum (2005) 0.93
The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) (2013) 0.93
Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis. Immunol Lett (2008) 0.91
Dual luciferase labelling for non-invasive bioluminescence imaging of mesenchymal stromal cell chondrogenic differentiation in demineralized bone matrix scaffolds. Biomaterials (2009) 0.91
Endogenous GATA factors bind the core sequence of the tetO and influence gene regulation with the tetracycline system. Mol Ther (2004) 0.89
Inhibitor of kappa B epsilon (IκBε) is a non-redundant regulator of c-Rel-dependent gene expression in murine T and B cells. PLoS One (2011) 0.89
Expansion of T-cell receptor zeta dim effector T cells in acute coronary syndromes. Arterioscler Thromb Vasc Biol (2008) 0.89
Human single-chain variable fragment that specifically targets arthritic cartilage. Arthritis Rheum (2010) 0.88
Themis2/ICB1 is a signaling scaffold that selectively regulates macrophage Toll-like receptor signaling and cytokine production. PLoS One (2010) 0.88
IL-12 and IL-10 expression synergize to induce the immune-mediated eradication of established colon and mammary tumors and lung metastasis. J Immunol (2005) 0.88
High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis? Arthritis Res Ther (2008) 0.88
Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor. Mol Med (2013) 0.88
Pathways of T cell activation and terminal differentiation in chronic inflammation. Curr Drug Targets Inflamm Allergy (2005) 0.87
Therapeutic improvement of a stroma-targeted CRAd by incorporating motives responsive to the melanoma microenvironment. J Invest Dermatol (2013) 0.87
Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3. Protein Eng Des Sel (2005) 0.87
Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmid. Arthritis Res Ther (2003) 0.86
Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses. PLoS One (2008) 0.85
Gene therapy with an improved doxycycline-regulated plasmid encoding a tumour necrosis factor-alpha inhibitor in experimental arthritis. Arthritis Res Ther (2007) 0.85
T-cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man. Immunol Cell Biol (2012) 0.84
Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum (2005) 0.84
TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues. Blood (2007) 0.84
Regulation of CD154-induced interleukin-12 production in synovial fluid macrophages. Arthritis Res (2002) 0.83
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial. Arthritis Res Ther (2014) 0.82
Molecular engineering of short half-life small peptides (VIP, αMSH and γ₃MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics. Ann Rheum Dis (2011) 0.81
Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide. Ann Rheum Dis (2012) 0.81
Latent cytokines for targeted therapy of inflammatory disorders. Expert Opin Drug Deliv (2013) 0.80
A novel hybrid promoter responsive to pathophysiological and pharmacological regulation. J Mol Med (Berl) (2011) 0.80
CD3ζ-chain expression of human T lymphocytes is regulated by TNF via Src-like adaptor protein-dependent proteasomal degradation. J Immunol (2012) 0.80
Novel delivery methods to achieve immunomodulation. Curr Opin Pharmacol (2007) 0.80
Expression analysis of Tudor-SN protein in mouse tissues. Tissue Cell (2012) 0.79
Methods for targeting biologicals to specific disease sites. Trends Mol Med (2004) 0.79
Proteomic analysis of the lymphocyte plasma membrane using cell surface biotinylation and solution-phase isoelectric focusing. Methods Mol Biol (2009) 0.78
Two-stage affinity purification for inducibly phosphorylated membrane proteins. Proteomics (2005) 0.78
A chimeric receptor of the insulin-like growth factor receptor type 1 (IGFR1) and a single chain antibody specific to myelin oligodendrocyte glycoprotein activates the IGF1R signalling cascade in CG4 oligodendrocyte progenitors. Biochim Biophys Acta (2011) 0.78
Increased disulphide dimer formation of latent associated peptide fusions of TGF-β by addition of L-cystine. J Biotechnol (2012) 0.78
Rheumatoid arthritis: a disease of chronic, low-amplitude signals transduced through T cell antigen receptors? Wien Med Wochenschr (2006) 0.77
Quantitative imaging of cartilage and bone for functional assessment of gene therapy approaches in experimental arthritis. J Tissue Eng Regen Med (2010) 0.77
Tracking antigen-experienced effector T cells in vitro and in vivo. Methods Mol Biol (2010) 0.77
Clustering of immunoreceptor tyrosine-based activation motif-containing signalling subunits in CD4(+) T cells is an optimal signal for IFN-gamma production, but not for the production of IL-4. Int Immunol (2003) 0.77
Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus expressing the 10A1 envelope protein. J Gene Med (2002) 0.77
Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscle. Curr Gene Ther (2015) 0.77
Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth. Mol Cancer Ther (2006) 0.76
Regulation of expression and function of Lck tyrosine kinase by high cell density. Mol Membr Biol (2005) 0.76
Mapping lymphocyte plasma membrane proteins: a proteomic approach. Methods Mol Med (2007) 0.76
Fibroblast-mediated delivery of GDNF induces neuronal-like outgrowth in PC12 cells. Otol Neurotol (2008) 0.76
Chronic back pain in patients with rheumatoid arthritis and in a control population: prevalence and disability--a 5-year follow-up. Rheumatology (Oxford) (2011) 0.76
Adding new perspectives to the kaleidoscope of remission criteria in rheumatoid arthritis. J Rheumatol (2013) 0.75
Comment on: Low TNF-induced NF-κB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford) (2011) 0.75
The importance of understanding the molecular mechanisms of resistance to biologics. Rheumatology (Oxford) (2011) 0.75
Engineering stem cells for therapy. Regen Med (2006) 0.75
The Relationship Between Mental Health, Disease Severity and Genetic Risk for Depression in Early Rheumatoid Arthritis. Psychosom Med (2017) 0.75
Correction. Immunoglobulin light chain allelic inclusion in systemic lupus erythematosus. Eur J Immunol (2015) 0.75
Latency can be conferred to a variety of cytokines by fusion with latency-associated peptide from TGF-β. Expert Opin Drug Deliv (2013) 0.75
Generation of an efficiently secreted, cell penetrating NF-κB inhibitor. FASEB J (2013) 0.75
[Exemplary cases of individualization of biological therapy]. Duodecim (2016) 0.75